Most Recent
Full Federal Court declines to clarify standard for patentability of computer-implemented inventions
A five-judge panel of the Full Federal Court has found two innovation patents by financial software company Encompass Corp. are not a manner of manufacture, but held back on providing more clarity on the test for the patentability of computer-implemented inventions.
‘We’re not in the realm of snake oil’: AFT appeals Maxigesic judgment
AFT Pharmaceuticals has challenged a Federal Court decision that found its Maxisegic ads were misleading and deceptive, saying the judge "set the bar too high" by requiring it to prove there was an adequate scientific foundation for its painkiller representations.
Copyright Tribunal overstepped with amended Foxtel licence, says Full Court
The Copyright Tribunal erred by including rights in a reissued Foxtel licence agreement that fell outside the authority of the licence grant holder, the Phonographic Performance Company of Australia, the Full Federal Court has found.
Judge slams Copyright Agency’s $32.5M interim request from universities as ‘absurd’ and ‘unfair’
A group of 39 of Australia’s largest universities has managed to avoid paying its full $32.5 million annual fee to Copyright Agency Ltd, while a dispute over the terms of a licence remains unresolved.
Novel challenge to IP Australia’s building patent grant dropped
A case simultaneously challenging IP Australia's decisions to accept, grant and certify an innovation patent owned by one of Australia's biggest building product companies has been withdrawn, a court has heard.
Reckitt using court to beat competitors, AFT tells judge in spat over Maxigesic ads
AFT Pharmaceuticals has accused rival Reckitt Benckiser of using the court as a "clearance house" to beat its competitors, the latest development in a long-running dispute over AFT's Maxigesic ads.
Mylan must hand over authorised generic docs ahead of injunction hearing
Pharmaceutical giant Mylan has been ordered to hand over documents relating to its proposed launch of a generic version of its cholesterol drug Lipidil to rival Sun Pharma in advance of a hearing on Mylan's request for an order blocking Sun from launching its own generic version of the drug.
Mylan wants injunctions against Sun Pharma, Cipla over generic cholesterol drug
Mylan has renewed calls for a temporary injunction against Sun Pharma pending an appeal of a ruling invalidating its patents for Lipidil, and has sued a second generic drug maker, Cipla, over the cholesterol-lowering medication.
Network 10 drops Boss name after legal action by Fairfax
A month after Network 10 vowed to fiercely defend against a trade mark infringement case by Fairfax Media over its new '10 Boss' logo, the TV broadcaster has agreed to drop the name.
IP Australia to call for dismissal of novel building patent case
The Commissioner of Patents will seek to toss a case simultaneously challenging its decisions to accept, grant and certify an innovation patent owned by one of Australia's biggest building product firms.